Remote monitoring for inflammatory bowel disease
Part of Digestive system clinical trials.
This trial tests whether remote monitoring, using an app and home stool tests, can be a safe alternative to frequent clinic visits for people with stable IBD. If you qualify, you'll have fewer in-person appointments and more flexibility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have Crohn's disease, ulcerative colitis, or IBD type unclassified.
- Your IBD treatment has been stable (or you've had no treatment) for at least two years.
- You haven't had IV biologics, steroids (except creams or inhalers), or IBD-related surgery in the past two years.
- You can speak, read, and write Dutch and have smartphone or internet access.
- You're willing to do at-home stool tests every three months, and blood tests as needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an app that lets you check in with your IBD care team only when you need to, instead of having regular appointments. It's for people with Crohn's disease or ulcerative colitis who are doing well and have been on the same medication for at least 3 months.
This study tests a smartphone app (SEMEIA) to help monitor people with active Crohn's disease or ulcerative colitis. It may help you track your symptoms and stay in touch with your doctor without needing as many office visits.
This trial tests a self-management program for people with active Crohn's disease or ulcerative colitis. It aims to improve quality of life by helping you better manage your condition.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
This study aims to improve care and reduce health gaps for people with inflammatory bowel disease using text-message surveys to track symptoms and guide better disease management.
This study looks at people with Crohn's disease or ulcerative colitis who are having a colonoscopy to check for abnormal cells in the colon. The goal is to learn more about these growths and how likely they are to become cancer over time, which could help improve future monitoring and treatment.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.